1 lical CT scan and detailed questioning about drug history.

2 rocurement of patients without a significant drug history.

3 on to polymorphism of the MOR gene OPRM1 and drug history.

4 ian cue-drug memories following an extensive drug history.

5  antidepressants (19% vs. 13%) and injection drug history (16% vs. 10%) were more frequent in the coh

6                                              Drug history and clinical outcome were analyzed.

7  approximately 23-fold as a function of past drug history and environmental condition.

8 ocation, and behaviour, previous medical and drug history, and previous Crohn's disease-related surge

9 t and should include a careful evaluation of drug history, clinical presentation, biological investig

10  observed between age, past medical history, drug history, gender, smoking, alcohol consumption, and

11   These findings highlight the importance of drug history in understanding the mechanisms through whi

12 istory of colorectal cancer, and smoking and drug history (mesalamine 5-aminosalicylic acid, azathiop

13 IV infection or ART, specific antiretroviral drugs, history of opportunistic infection, immune status

14 r age, white race, history of use of illicit drugs, history of other drug use disorders, and history

15  facial expression, intellectual disability, drug history or demographic differences.

16 mputer interacting with 3 databases: patient drug history, scientific drug information and guideline

17                                     Detailed drug history was collected for all patients at discharge

18 (COVID-19) and vaccine history, medical, and drug history were extracted from questionnaires and medi